Annette Dale-Perera

Overview of some international initiatives on quality in treatment

Annette Dale-Perera - 15 February 2021
A 30 minute YouTube lecture giving an overview of some International initiatives on quality in drug use disorder treatment services and systems. The lecture is given by Annette Dale-Perera and was filmed in Autumn 2020 by UNODC
Rasha Abi Hana

Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017

Shared by Rasha Abi Hana - 25 October 2021
Citation
Bounthavong, M., Suh, K., Li, M. et al. Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017. Subst Abuse Treat Prev Policy 16, 80 (2021). https://doi.org/10.1186/s13011-021-00415-5
Publication Date

One of the most serious public health concerns in recent decades has been the opioid epidemic in the United States (US). Over 9.9 million Americans aged 12 and up abused prescription pain drugs in 2018, and roughly 2 million Americans were diagnosed with opioid use disorder. In 2019, 49,860 drug...

Edie

INL's Webinar Week

Shared by Edie - 15 October 2021

The U.S. Department of State's Bureau of International Narcotics and Law Enforcement Affairs (INL) presents the third annual event on partnering with the private sector to address the world drug problem.

The private sector can play a major role in preventing and combating the manufacture, diversion, sale, and misuse of drugs and precursors by mobilizing its unique resources, technologies, and expertise.

Throughout webinar week, INL will showcase the important role the private sector can play in addressing distinct aspects of the world drug problem, and how government and business can...

James

Implementing quality standards for drug services and systems: a six-step guide to support quality assurance

Shared by James - 7 October 2021
ISSUP EMCDDA
Published by
EMCDDA
Publication Date
This publication provides a practical introduction to the area of quality standards and quality assurance mechanisms and the key steps involved in their implementation in drug services and systems.
Rasha Abi Hana

Psychosocial Interventions to Improve Psychological, Social and Physical Wellbeing in Family Members Affected by an Adult Relative’s Substance Use: A Systematic Search and Review of the Evidence

Shared by Rasha Abi Hana - 24 September 2021
Citation
McGovern, R., Smart, D., Alderson, H., Araújo-Soares, V., Brown, J., Buykx, P., Evans, V., Fleming, K., Hickman, M., Macleod, J., Meier, P., & Kaner, E. (2021). Psychosocial Interventions to Improve Psychological, Social and Physical Wellbeing in Family Members Affected by an Adult Relative's Substance Use: A Systematic Search and Review of the Evidence. International journal of environmental research and public health, 18(4), 1793. https://doi.org/10.3390/ijerph18041793
Publication Date

The use of alcohol and drugs is a significant public health concern and is prevalent in families. Over 100 million people are thought to be affected by a close relative's substance use, with many experiencing negative health and social consequences. Additional associated stressors, such as...

Rasha Abi Hana

Identifying content-based engagement patterns in a smoking cessation website and associations with user characteristics and cessation outcomes: a sequence and cluster analysis

Shared by Rasha Abi Hana - 20 August 2021
Citation
Olga Perski, PhD, Noreen L Watson, PhD, Kristin E Mull, MS, Jonathan B Bricker, PhD, Identifying Content-Based Engagement Patterns in a Smoking Cessation Website and Associations With User Characteristics and Cessation Outcomes: A Sequence and Cluster Analysis, Nicotine & Tobacco Research, Volume 23, Issue 7, July 2021, Pages 1103–1112, https://doi.org/10.1093/ntr/ntab008
Publication Date

Tobacco smoking is the greatest cause of sickness and early death worldwide, with 8 million people dying each year from a smoking-related condition. The use of pharmaceutical or behavioural assistance improves smokers' chances of quitting; nonetheless, the majority of smoking cessation efforts are...

Rasha Abi Hana

Gender disparities in opioid treatment progress in methadone versus counselling

Shared by Rasha Abi Hana - 22 July 2021
Citation
Guerrero, E., Amaro, H., Kong, Y. et al. Gender disparities in opioid treatment progress in methadone versus counseling. Subst Abuse Treat Prev Policy 16, 52 (2021). https://doi.org/10.1186/s13011-021-00389-4
Publication Date

The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in...

Rasha Abi Hana

High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder

Shared by Rasha Abi Hana - 22 July 2021
Citation
Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128
Publication Date

In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of opioid use disorder (OUD). The objective of this study is to...

Rasha Abi Hana

Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centres with SBIRT services

Shared by Rasha Abi Hana - 19 July 2021
Citation
Watson, D.P., Staton, M.D., Dennis, M.L. et al. Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centers with SBIRT services. Subst Abuse Treat Prev Policy 16, 58 (2021). https://doi.org/10.1186/s13011-021-00381-y
Publication Date

Brief treatment (BT) or regular outpatient alcohol use or substance use disorder (SUD) treatment is a key element of the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model. It can be an effective, short-term, and low-cost treatment option for many people who misuse alcohol and...

Rasha Abi Hana

Reporting treatment fidelity in behavioral tobacco treatment clinical trials: scoping review and measurement recommendations

Shared by Rasha Abi Hana - 3 July 2021
Citation
Ramzi G Salloum, Alana M Rojewski, Megan E Piper, Janice A Blalock, Belinda Borrelli, Lindsay M Boyce, Jennifer A Minnix, Omara Dogar, Rachel L Tomko, Douglas E Jorenby, Chris Kotsen, Jamie S Ostroff, Treatment Fidelity Workgroup of the SRNT Treatment Network, Reporting Treatment Fidelity in Behavioral Tobacco Treatment Clinical Trials: Scoping Review and Measurement Recommendations, Nicotine & Tobacco Research, 2021;, ntab140, https://doi.org/10.1093/ntr/ntab140
Publication Date

Abstract

Introduction:

Adoption of rigorous standards for reporting treatment fidelity is essential for advancing discovery, validation, and implementation of behavioral treatments. Whereas the NIH Behavior Change Consortium (BCC) developed an assessment tool to assess quality of reporting and...

Rasha Abi Hana

Chronic care treatment for smoking cessation in patients with serious mental illness: a pilot randomized trial

Shared by Rasha Abi Hana - 28 June 2021
Citation
Busch, A.M., Nederhoff, D.M., Dunsiger, S.I. et al. Chronic care treatment for smoking cessation in patients with serious mental illness: a pilot randomized trial. BMC Psychiatry 21, 104 (2021). https://doi.org/10.1186/s12888-021-03113-5
Publication Date

Background:

Rates of smoking among those with serious mental illness (SMI) are two to three times higher than for the general population. Smoking is rarely addressed in mental health settings. Innovative outreach and treatment strategies are needed to address these disparities. The current study...

Rasha Abi Hana

Disentangling substance use and related problems: urgency predicts substance-related problems beyond the degree of use

Shared by Rasha Abi Hana - 26 June 2021
Citation
Hildebrandt, M.K., Dieterich, R. & Endrass, T. Disentangling substance use and related problems: urgency predicts substance-related problems beyond the degree of use. BMC Psychiatry 21, 242 (2021). https://doi.org/10.1186/s12888-021-03240-z
Publication Date

Background:

Substance use disorders are reliably associated with high impulsivity and sensation seeking. Importantly, both precede problematic substance use, implicating them as risk factors. Individuals with substance use disorders show variable degrees of substance use (combined quantity and...

Rasha Abi Hana

Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life

Shared by Rasha Abi Hana - 26 June 2021
Citation
Lien, L., Bolstad, I. & Bramness, J.G. Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life. BMC Psychiatry 21, 244 (2021). https://doi.org/10.1186/s12888-021-03252-9
Publication Date

Background:

Smoking is still prevalent among people with substance use disorders. The objective of this study was to investigate the prevalence of smoking among patients in treatment for substance use disorders and to analyze the effect of smoking both at baseline and follow-up on drop-out...

James

World Drug Report 2021

Shared by James - 25 June 2021
Published by
UNODC
Publication Date
Consisting of five separate booklets, the World Drug Report 2021 provides an in-depth analysis of the global drug markets and paints a comprehensive picture of the measurable effects and potential impact of the COVID-19 crisis on the world drug problem.
Olivia Woodrow

Quality Assurance (QA) of the Drug Treatment Services in Pakistan

Shared by Olivia Woodrow - 10 June 2021
Publication Date
Format
ISSUP Webinars

The ISSUP Quality in Treatment Network and ISSUP Pakistan, in collaboration with MNC, UNODC and INL, are pleased to present their webinar on Quality Assurance (QA) of the Drug Treatment Services in Pakistan.

The webinar will bring together a panel of experts who will provide insights into the UNODC Drug Use Disorder Treatment Systems, Quality Assurance Toolkit, five standards, and lessons learnt in four provincial trainings conducted in Pakistan during March 2021 for drug use disorder treatment professionals.

The Ministry of Narcotics Control will be presenting the Government of Pakistan mandate and efforts to deal the issue. ISSUP Pakistan will present on how to plan interventions that address the subject of bringing quality in substance use treatment in line with the WHO/UNODC 2020 International Standards for the Treatment of Drug Use Disorders.

The following themes will be covered in the webinar:

  • 5 system standards for QA of Drug treatment as per the UNODC Drug Use Disorder Treatment Systems, Quality Assurance Toolkit, and a summary of the key findings of the recent national and provincial System QA training in Pakistan.
  • Ministry of Narcotics Control (GoP) vision and plans to improve the drug treatment systems in Pakistan. 
  • ISSUP Pakistan will be presenting steps and action plan to improve quality of the drug treatment systems in Pakistan through its members network.

Opening Remarks:

1. Ms. Olha Myshakivska, National Chapters Coordinator ISSUP

2. Mr. Sabino Sikandar Jalal, Senior Joint Secretary, Ministry of Narcotics Control, Government of Pakistan

3. Dr. Jeremy Milsom, Country Representative, UNODC Pakistan

4. Ms. Cristian Martinez-LuSane, INL-Pakistan Program Officer, Counternarcotics, Corrections, Rule of Law

 

Panelists:

Annette Dale-Perera  Ms. Annette Dale-Perera

  Director of ADP Consultancy
  Consultant, UNODC/WHO and Colombo Plan 

Sabino Sikandar Jalal  Mr. Sabino Sikandar Jalal


  Designation: Senior Joint Secretary
  Ministry: Ministry of Narcotics Control, Government of Pakistan

Saima Asghar  Ms. Saima Asghar


  Social Worker
  Director, ISSUP Pakistan Chapter

 

Country
Pakistan
Resource Language

English

Attachments
Attachment Size
Annette Dale-Perera - Presentation Slides 9.79 MB
Saima Asghar - Presentation Slides 144.32 KB
Themes
Quality in Treatment
Partner Organisation
ISSUP Pakistan
Tags (Keywords)
quality in treatment
Pakistan
Quality Assurance
quality standards
Issup Pakistan
Annette Dale-Perera

New Quality Standards for Opioid Medication Assisted Treatment in Scotland

Annette Dale-Perera - 1 June 2021
New treatment standards
Scotland has just published new quality Standards for opioid Medicated Assisted Treatment. Scotland has the highest level of opioid-related overdose deaths in the UK. The new standards for treatment for people who use opioids are designed to ensure everyone has access to the support which works best...
Diana Crossan

Consumo de sustancias psicoactivas y perspectiva de género. En la semana del Día Internacional de Acción por la Salud de la Mujer

Shared by Diana Crossan - 1 April 2021
Argentina

ISSUP Argentina invites you to participate in a webinar that will discuss psychoactive substance use and gender perspective - in the week of the International Day of Action for Women's Health. The webinar will take place on May 21, 2021 at...

Annette Dale-Perera

System Quality Assurance training in Pakistan

Annette Dale-Perera - 10 March 2021
On-line System QA training in Sindh Province
Following national training in October of 2020, March 2021 is the month UNODC are conducting 4 Provincial 4-day trainings in Drug Treatment System Quality Assurance. We are helping local experts analyse provincial system quality - to see if they are in line with the 'International Standards for the Treatment of Drug Use Disorders' WHO/UNODC 2020. We are looking at Provincial planning mechanisms, local need, whether service provision is in line with international guidance, provincial plans and resources, and provincial quality assurance and workforce planning. Last week was Punjab, this week is...
Annette Dale-Perera

Quality in Treatment Network Launch webinar

Annette Dale-Perera - 26 February 2021
https://www.issup.net/professional-development/quality-treatment
The Launch of the Quality in Treatment Network Webinar featuring Chair: Annette Dale-Perera on why create this network US State Department (INL) Charlotte Sisson) on why quality in treatment important Anja Busse (UNODC) overview of UNODC work on Quality in Treatment’ Dr Auwal Salihu/ Dr Akanidomo...

Upcoming Events

There aren't any upcoming events
Contact Us
Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy